Recent Articles
How One-Stop Antibody Customizat...
What Technical Support Is Requir...
What Does Antibody Customization...
PTEN Companion Diagnostic Antibodies Direct Precision Cancer Therapy
1. Literature Information This review establishes PTEN as a key tumor suppressor and demonstrates that PTEN IHC is a reliable companion diagnostic to predict PI3K/AKT/mTOR inhibitor response and immunotherapy efficacy....
PTEN Companion Diagnostic Antibodies Direct Precision Cancer Therapy
1. Literature Information This review establishes PTEN as a key tumor suppressor and demonstrates that PTEN IHC is a reliable companion diagnostic to predict PI3K/AKT/mTOR inhibitor response and immunotherapy efficacy....
Read More
FRα Antibody Guides Targeted Therapy Decisions for Ovarian Cancer
1. Literature Information This research highlights FRα as a pivotal target in ovarian cancer and validates FRα antibodybased IHC as a critical tool to select patients for FRαtargeted ADC therapy....
FRα Antibody Guides Targeted Therapy Decisions for Ovarian Cancer
1. Literature Information This research highlights FRα as a pivotal target in ovarian cancer and validates FRα antibodybased IHC as a critical tool to select patients for FRαtargeted ADC therapy....
Read More
FRα Companion Diagnostic Antibody Guides Precision ADC Therapy
1. Literature Information This study establishes FRα (FOLR1) as a validated biomarker for ADC therapy and demonstrates that FRα IHC is a clinically approved companion diagnostic to identify eligible patients....
FRα Companion Diagnostic Antibody Guides Precision ADC Therapy
1. Literature Information This study establishes FRα (FOLR1) as a validated biomarker for ADC therapy and demonstrates that FRα IHC is a clinically approved companion diagnostic to identify eligible patients....
Read More
Nectin-4 Antibody: A Rising Star in Solid Tumor Targeted Therapy
1. Literature Information This review summarizes Nectin4 as a leading target for ADCs and emphasizes the essential role of Nectin4 antibodies in patient selection across bladder, breast, ovarian, lung, and...
Nectin-4 Antibody: A Rising Star in Solid Tumor Targeted Therapy
1. Literature Information This review summarizes Nectin4 as a leading target for ADCs and emphasizes the essential role of Nectin4 antibodies in patient selection across bladder, breast, ovarian, lung, and...
Read More
Nectin-4 Companion Diagnostic Antibodies Guide Precision Therapy for Solid Tu...
1. Literature Information This work defines Nectin4 (PVRL4) as a validated target for ADC therapy and establishes Nectin4 IHC as a standard companion diagnostic to select patients with urothelial, breast,...
Nectin-4 Companion Diagnostic Antibodies Guide Precision Therapy for Solid Tu...
1. Literature Information This work defines Nectin4 (PVRL4) as a validated target for ADC therapy and establishes Nectin4 IHC as a standard companion diagnostic to select patients with urothelial, breast,...
Read More
FGFR2b Antibody: A New Hope for Targeted Therapy in Gastric Cancer
1. Literature Information This review highlights FGFR2b as a pivotal therapeutic target in gastric cancer and demonstrates the critical role of FGFR2b companion diagnostic antibodies in patient screening and precision...
FGFR2b Antibody: A New Hope for Targeted Therapy in Gastric Cancer
1. Literature Information This review highlights FGFR2b as a pivotal therapeutic target in gastric cancer and demonstrates the critical role of FGFR2b companion diagnostic antibodies in patient screening and precision...
Read More